A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)
PHASE1
Evaluate the safety and tolerability of sotorasib in adult subjects with KR...
An Open-label, Phase 2trial of Sotorasib in KRAS G12C-mutant Non-small-cell Lung Cancer(NSCLC) Patients and a Translational Study to Find Acquired Resistance Mechanism to Sotorasib
PHASE2
Lung cancer is the most common type of cancer occurring in both males and f...
Status
Unknown
Location
Yonsei University Health System, Severance Hospital
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
PHASE3
The aim of this study is to compare progression free survival (PFS) in trea...